Vanda Pharmaceuticals Inc.
Qualité des données : 100%
VNDA
NASDAQ
Manufacturing
Chemicals
7,32 €
▲
0,16 €
(2,23%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-5,30%
Croissance
Revenue Growth (5Y)
-5,30%
En dessous de la moyenne du secteur (1,82%)
Revenue (1Y)8,72%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-46,30%
Au-dessus de la moyenne du secteur (-54,49%)
ROIC-24,21%
Net Margin-102,02%
Op. Margin-69,95%
Sécurité
Debt / Equity
N/A
Current Ratio3,12
Interest CoverageN/A
Valorisation
PE (TTM)
-1,95
En dessous de la moyenne du secteur (-1,50)
P/B Ratio0,92
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -5,30% annually over 5 years
Negative free cash flow of -110,44 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 14,02%
Capital efficient — spends only 0,46% of revenue on capex
Price History
Tendances Financières
Objectif de Cours des Analystes
5 analystes
Buy
+111.7%
upside to target
Actuel
7,32 €
Consensus Target
15,50 €
7,50 €
Bas
24,00 €
Haut
Prévisions
BPA Prévisionnel
-0,79 €
CA Est.
353,27 M
Surprises de Résultats
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -0,69 €
·
Rev Est: 55,04 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -0,50 € | -0,46 € | -0,38 € | -2,39 € | — | — |
| Estimate | -0,60 € | -0,36 € | -0,45 € | -1,33 € | -0,69 € | -0,57 € |
| Surprise | +16,20% | -28,97% | +16,18% | -80,38% | — | — |
Growth
Rev 5Y: -5,30% · Earnings 1Y: N/A
Growth
Rev 5Y: -5,30% · Earnings 1Y: N/A| Revenue Growth (1Y) | 8,72% | Revenue Growth (3Y) | 5,92% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -5,30% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -46,30% · Net Margin: -102,02%
Profitability
ROE: -46,30% · Net Margin: -102,02%| Revenue (TTM) | 216,11 M | Net Income (TTM) | -220,47 M |
| ROE | -46,30% | ROA | -35,97% |
| Gross Margin | N/A | Operating Margin | -69,95% |
| Net Margin | -102,02% | Free Cash Flow (TTM) | -110,44 M |
| ROIC | -24,21% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 3,12
Safety
D/E: N/A · Current: 3,12| Debt / Equity | N/A | Current Ratio | 3,12 |
| Interest Coverage | N/A | Asset Turnover | 0,35 |
| Working Capital | 249,63 M | Tangible Book Value | 357,16 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -1,95 · EV/EBITDA: N/A
Valuation
P/E: -1,95 · EV/EBITDA: N/A| P/E Ratio | -1,95 | Forward P/E | N/A |
| P/B Ratio | 0,92 | P/S Ratio | 1,99 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1,22 | Fwd Earnings Yield | N/A |
| FCF Yield | -25,68% | ||
| Market Cap | 430,01 M | Enterprise Value | 359,99 M |
Per Share
EPS: -3,74 · FCF/Share: -1,87
Per Share
EPS: -3,74 · FCF/Share: -1,87| EPS (Diluted TTM) | -3,74 | Revenue / Share | 3,66 |
| FCF / Share | -1,87 | OCF / Share | -1,85 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 50,09% · CapEx/Rev: 0,46%
Efficiency
FCF Conv: 50,09% · CapEx/Rev: 0,46%| CapEx / Revenue | 0,46% | FCF Conversion | 50,09% |
| SBC-Adj. FCF | -120,63 M | Growth Momentum | 14,02 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 216,11 M | 198,77 M | 192,64 M | 254,38 M | 268,68 M |
| Net Income | -220,47 M | -18,90 M | 2,51 M | 6,28 M | 33,15 M |
| EPS (Diluted) | -3,74 | -0,33 | 0,04 | 0,11 | 0,58 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -151,17 M | -40,66 M | -13,95 M | 6,33 M | 42,17 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 109,27 M | 74,43 M | 76,82 M | 85,77 M | 75,36 M |
| SG&A Expenses | 237,95 M | 146,41 M | 112,88 M | 136,49 M | 124,05 M |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 81,83 M | -4,02 M | 3,83 M | 5,03 M | 9,21 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 488,95 M | 656,20 M | 648,44 M | 634,25 M | 593,79 M |
| Total Liabilities | 161,76 M | 117,66 M | 103,53 M | 107,05 M | 88,86 M |
| Shareholders' Equity | 327,19 M | 538,55 M | 544,91 M | 527,20 M | 504,93 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 84,85 M | 102,32 M | 135,82 M | 135,03 M | 52,07 M |
| Current Assets | 347,26 M | 438,89 M | 432,95 M | 519,29 M | 478,30 M |
| Current Liabilities | 145,16 M | 99,98 M | 87,70 M | 91,44 M | 74,42 M |
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs)
Par rapport à des entreprises similaires dans Manufacturing
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1605 pairs) Par rapport à des entreprises similaires dans Manufacturing| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -2,0 | -1,5 |
| P/B | 0,9 | 1,6 |
| ROE % | -46,3 | -54,5 |
| Net Margin % | -102,0 | -41,5 |
| Rev Growth 5Y % | -5,3 | 1,8 |
| D/E | — | 0,3 |
{"event":"ticker_viewed","properties":{"ticker":"VNDA","listing_kind":"stock","pathname":"/stocks/vnda","exchange":"NASDAQ","country":"US"}}